Skip to main content
. 2019 Feb 17;2019:9356728. doi: 10.1155/2019/9356728

Table 2.

Chemokine, growth factor, angiogenetic factor, and wound healing factor concentration in aqueous humor of a control group and patients with pOT and rOT (n = 62).

Immune mediator Mdn concentration in patients with pOT, n = 21 (IQR) (pg/ml) Mdn concentration in patients with rOT, n = 30 (IQR) (pg/ml) Mdn concentration in patients in the control group, n = 11 (IQR) (pg/ml) pOT vs control p value rOT vs control p value pOT vs rOT p value
T cell development-promoting cytokine
IL-2 183 (0, 315) 123 (0, 233) 0 (0, 0) <0.001 0.003 0.324
Th1-cytokines
IFN-γ 760 (218, 2.93103) 348 (62.7, 909) 0 (0, 0) <0.0001 <0.001 0.129
TNF-α 55.2 (15.6, 111.4) 22.6 (4.53, 64.9) 0 (0, 0) <0.00001 <0.001 0.104
Th1 cell development-promoting cytokines
IL-12p70 233 (114, 423) 132 (81.2, 289) 192 (158, 384) 0.761 0.205 0.241
IL-7 654 (464, 1.19103) 450 (318, 937) 772 (532, 851) 0.916 0.097 0.028
IL-15 79.8 (39.9, 217) 47.5 (12.5, 136.5) 0 (0, 23.4) <0.0001 0.004 0.084
Th2 cytokines
IL-4 29.4 (4.48, 59.6) 16.2 (0, 38.6) 0 (0, 0) <0.0001 <0.001 0.183
IL-5 49.2 (22.8, 149) 37.1 (15.5, 93.6) 0 (0, 0) <0.0001 <0.001 0.380
IL-9 135 (58.7, 345) 93.5 (14.9, 205) 0 (0, 0.62) <0.00001 0.001 0.054
IL-10 67.9 (2.43, 176) 19.8 (0, 102) 1.99 (1.59, 49.8) 0.106 0.521 0.188
IL-13 345.4 (204, 1.05103) 194 (77.9, 647) 230 (103, 286) 0.022 0.402 0.051
Th17 cytokines
IL-17 79.9 (0, 371) 0 (0, 234) 0 (0, 0) 0.001 0.014 0.237
IL-1Rα 262 (53.5, 648) 130 (0, 337) 0 (0, 0) <0.0001 0.002 0.207
Th17 cell development-promoting cytokines
IL-6 2.74∗103 (738, 6.01∗103) 1.06∗103 (173, 3.99∗103) 150 (1.54, 409) <0.0001 0.004 0.108
IL-1β 3.96 (0.57, 8.11) 1.38 (0, 5.36) 0 (0, 1.49) 0.003 0.032 0.220

pOT: primary OT; rOT: recurrent OT: Mdn: median; IQR: interquartile range; significant p values are shown in bold; italic values are below LLOQ as defined by the manufacturer.